CLA and mouse lipoatrophic syndrome

Abstract : Conjugated linoleic add (CLA) refers to a class of positional and geometric dienoic isomers of linoleic acid. Chronic dietary supplementation with a commercial mixture containing c9,t11-CLA and t10,c12-CLA in equimolar quantity leads to a drop in fat mass in various species. The t10,c12-CLA isomer is responsible for this anti-obesity effect. The reduction of fat mass is especially dramatic in the mouse, in which it is associated with a severe hyperinsulinemia, an insulin resistance and a massive liver steatosis. The origin of these adverse side effects and the putative chronology of events leading to CLA-mediated lipoatrophic syndrome are presented and discussed in this review.
Document type :
Journal articles
Complete list of metadatas

https://hal-agrosup-dijon.archives-ouvertes.fr/hal-01917127
Contributor : Administrateur Agrosupdijon <>
Submitted on : Friday, November 9, 2018 - 10:25:35 AM
Last modification on : Tuesday, June 4, 2019 - 10:30:05 AM

Identifiers

Citation

Philippe Besnard, Hélène Poirier, Isabelle Niot, Michèle Guerre-Millo. CLA and mouse lipoatrophic syndrome. Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids, Elsevier, 2005, 1735 (1), pp.41 - 49. ⟨10.1016/j.bbalip.2005.05.002⟩. ⟨hal-01917127⟩

Share

Metrics

Record views

12